Genotypic to Phenotypic Resistance Discrepancies Identified Involving β-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae

References

• Bush K, Bradford PA. Beta-lactams and beta-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. 2016;6(8):a025247. doi:10.1101/cshperspect.a02524727329032
   PubMed Web of Science ®Google Scholar
• Knott-Hunziker V, Waley SG, Orlek BS, Sammes PG. Penicillinase active sites: labelling of serine-44 in beta-lactamase I by 6beta-bromopenicillanic acid. FEBS Lett. 1979;99(1):59–61. doi:10.1016/0014-5793(79)80248-3220094
   PubMed Web of Science ®Google Scholar
• Zhang H, Hao Q. Crystal structure of NDM-1 reveals a common beta-lactam hydrolysis mechanism. FASEB J. 2011;25(8):2574–2582. doi:10.1096/fj.11-18403621507902
   PubMed Web of Science ®Google Scholar
• Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980;289(1036):321–331.6109327
   PubMed Web of Science ®Google Scholar
• Sacha P, Ostas A, Jaworowska J, et al. The KPC type beta-lactamases: new enzymes that confer resistance to carbapenems in Gram-negative bacilli. Folia Histochem Cytobiol. 2009;47(4):537–543. doi:10.2478/v10042-009-0079-y20430717
   PubMed Web of Science ®Google Scholar
• Bush K. Past and present perspectives on beta-lactamases. Antimicrob Agents Chemother. 2018;62(10). doi:10.1128/AAC.01076-18
   Web of Science ®Google Scholar
• Tehrani K, Martin NI. Beta-lactam/beta-lactamase inhibitor combinations: an update. Medchemcomm. 2018;9(9):1439–1456. doi:10.1039/C8MD00342D30288219
   PubMed Web of Science ®Google Scholar
• Powers RA. Structural and functional aspects of extended-spectrum AmpC cephalosporinases. Curr Drug Targets. 2016;17(9):1051–1060. doi:10.2174/157339981166615061514470726073861
   PubMed Web of Science ®Google Scholar
• Kotsakis SD, Caselli E, Tzouvelekis LS, Petinaki E, Prati F, Miriagou V. Interactions of oximino-substituted boronic acids and beta-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42. Antimicrob Agents Chemother. 2013;57(2):968–976. doi:10.1128/AAC.01620-1223229484
   PubMed Web of Science ®Google Scholar
• Docquier JD, Mangani S. Structure-function relationships of class D carbapenemases. Curr Drug Targets. 2016;17(9):1061–1071. doi:10.2174/138945011666615082511582426302798
   PubMed Web of Science ®Google Scholar
• Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006;57(3):373–383. doi:10.1093/jac/dki48216446375
   PubMed Web of Science ®Google Scholar
• Emeraud C, Escaut L, Boucly A, et al. Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-beta-lactamase-producing gram-negative bacteria. Antimicrob Agents Chemother. 2019;63(5). doi:10.1128/AAC.00010-19.
   Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–175. doi:10.1038/nprot.2007.52118274517
   PubMed Web of Science ®Google Scholar
• Gibb AP, Tribuddharat C, Moore RA, et al. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7). Antimicrob Agents Chemother. 2002;46(1):255–258. doi:10.1128/AAC.46.1.255-258.200211751148
   PubMed Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046–5054. doi:10.1128/AAC.00774-0919770275
   PubMed Web of Science ®Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602. doi:10.1016/S1473-3099(10)70143-220705517
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Giamarellou H, Rossolini GM. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis. 2011;11(5):381–393. doi:10.1016/S1473-3099(11)70056-121530894
   PubMed Web of Science ®Google Scholar
• Pournaras S, Poulou A, Voulgari E, Vrioni G, Kristo I, Tsakris A. Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae. J Antimicrob Chemother. 2010;65(8):1604–1607. doi:10.1093/jac/dkq19020522444
   PubMed Web of Science ®Google Scholar
• Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543(7643):15. doi:10.1038/nature.2017.2155028252092
   PubMed Web of Science ®Google Scholar
• Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-resistant enterobacteriaceae: a strategic roadmap for infection control. Infect Control Hosp Epidemiol. 2017;38(5):580–594. doi:10.1017/ice.2017.4228294079
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing enterobacteriaceae. Clin Microbiol Rev. 2018;31(2).
   PubMed Web of Science ®Google Scholar
• Kelly AM, Mathema B, Larson EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents. 2017;50(2):127–134. doi:10.1016/j.ijantimicag.2017.03.01228647532
   PubMed Web of Science ®Google Scholar
• Arana DM, Rubio M, Alos JI. Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: a 12-year analysis (2003–2014). Enferm Infecc Microbiol Clin. 2017;35(5):293–298. doi:10.1016/j.eimc.2016.02.01827056582
   PubMed Web of Science ®Google Scholar
• Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw28228375512
   PubMed Web of Science ®Google Scholar
• Melgarejo JL, Cardoso MH, Pinto IB, et al. Identification, molecular characterization, and structural analysis of the blaNDM-1 gene/enzyme from NDM-1-producing Klebsiella pneumoniae isolates. J Antibiot (Tokyo). 2019;72(3):155–163. doi:10.1038/s41429-018-0126-z30479395
   PubMed Web of Science ®Google Scholar
• Balm MN, La MV, Krishnan P, Jureen R, Lin RT, Teo JW. Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases. Clin Microbiol Infect. 2013;19(9):E421–423. doi:10.1111/1469-0691.1224723668475
   PubMed Web of Science ®Google Scholar
• Davis MA, Besser TE, Orfe LH, et al. Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use. Appl Environ Microbiol. 2011;77(10):3293–3299. doi:10.1128/AEM.02588-1021421795
   PubMed Web of Science ®Google Scholar
• Pink RC, Wicks K, Caley DP, Punch EK, Jacobs L, Carter DR. Pseudogenes: pseudo-functional or key regulators in health and disease? RNA. 2011;17(5):792–798. doi:10.1261/rna.265831121398401
   PubMed Web of Science ®Google Scholar
• Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004;38(8):1150–1158. doi:10.1086/38302915095222
   PubMed Web of Science ®Google Scholar
• Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med. 1982;307(8):463–468. doi:10.1056/NEJM1982081930708027099208
   PubMed Web of Science ®Google Scholar
• Odoki M, Almustapha Aliero A, Tibyangye J, et al. Prevalence of bacterial urinary tract infections and associated factors among patients attending hospitals in Bushenyi District, Uganda. Int J Microbiol. 2019;2019:4246780. doi:10.1155/2019/424678030906323
   PubMed Web of Science ®Google Scholar
• van der Zee A, Roorda L, Bosman G, Ossewaarde JM, Lin B. Molecular diagnosis of urinary tract infections by semi-quantitative detection of uropathogens in a routine clinical hospital setting. PLoS One. 2016;11(3):e0150755. doi:10.1371/journal.pone.015075526954694
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th Wayne, PA, USA:Clinical and Laboratory Standards Institute; 2018
   Google Scholar
• Institute. CaLS. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Eighth Edition. Wayne, PA, USA: CLSI; 2009
   Google Scholar
• Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55(11):4943–4960. doi:10.1128/AAC.00296-1121859938
   PubMed Web of Science ®Google Scholar
• Testing. ECoAS. Breakpoint tables for interpretation of MICs and zone diameters. EUCAST. 2017; Version 7.1.
   Google Scholar
• Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.00221398074
   PubMed Web of Science ®Google Scholar
• Senda K, Arakawa Y, Ichiyama S, et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol. 1996;34(12):2909–2913. doi:10.1128/JCM.34.12.2909-2913.19968940421
   PubMed Web of Science ®Google Scholar
• Hooton TM. Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother. 2000;46(90001):1–7. doi:10.1093/jac/46.suppl_1.1
   Web of Science ®Google Scholar
• Begum N, Shamsuzzaman SM. Emergence of carbapenemase-producing urinary isolates at a tertiary care hospital in Dhaka, Bangladesh. Ci Ji Yi Xue Za Zhi. 2016;28(3):94–98. doi:10.1016/j.tcmj.2016.04.00528757733
   PubMedGoogle Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228–236. doi:10.1016/S1473-3099(09)70054-419324295
   PubMed Web of Science ®Google Scholar
• Chen Z, Qlu S, Wang Y, et al. Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clin Infect Dis. 2011;52(5):692–693. doi:10.1093/cid/ciq23121292674
   PubMed Web of Science ®Google Scholar
• Canton R, Ruiz-Garbajosa P. Co-resistance: an opportunity for the bacteria and resistance genes. Curr Opin Pharmacol. 2011;11(5):477–485. doi:10.1016/j.coph.2011.07.00721840259
   PubMed Web of Science ®Google Scholar
• Bengtsson-Palme J, Kristiansson E, Larsson DGJ. Environmental factors influencing the development and spread of antibiotic resistance. FEMS Microbiol Rev. 2018;42(1). doi:10.1093/femsre/fux053
   Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657–686. doi:10.1128/CMR.18.4.657-686.200516223952
   PubMed Web of Science ®Google Scholar
• Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933–951, table of contents. doi:10.1128/CMR.14.4.933-951.200111585791
   PubMed Web of Science ®Google Scholar
• Naas T, Dortet L, Iorga BI. Structural and functional aspects of class A carbapenemases. Curr Drug Targets. 2016;17(9):1006–1028. doi:10.2174/138945011766616031014450126960341
   PubMed Web of Science ®Google Scholar
• Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev. 2007;20(1):79–114. doi:10.1128/CMR.00015-0617223624
   PubMed Web of Science ®Google Scholar
• Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol. 2019;17(8):479–496. doi:10.1038/s41579-019-0218-131235888
   PubMed Web of Science ®Google Scholar
• Nicoloff H, Hjort K, Levin BR, Andersson DI. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat Microbiol. 2019;4(3):504–514. doi:10.1038/s41564-018-0342-030742072
   PubMed Web of Science ®Google Scholar
• Hughes D, Andersson DI. Environmental and genetic modulation of the phenotypic expression of antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):374–391. doi:10.1093/femsre/fux00428333270
   PubMed Web of Science ®Google Scholar
• Minardi D, d’Anzeo G, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: etiology and treatment options. Int J Gen Med. 2011;4:333–343. doi:10.2147/IJGM.S1176721674026
   PubMedGoogle Scholar
• Akoachere JF, Yvonne S, Akum NH, Seraphine EN. Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns. BMC Res Notes. 2012;5:219. doi:10.1186/1756-0500-5-21922564344
   PubMedGoogle Scholar
• Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care. 2010;14(3):R113. doi:10.1186/cc906220546564
   PubMed Web of Science ®Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–E3470. doi:10.1073/pnas.171729511529581252
   PubMed Web of Science ®Google Scholar